BSE Healthcare News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on BSE Healthcare from all sources in a single place.

Load latest

Metropolis Healthcare Ltd.

07 Apr 2025, 08:27AM

1485.15

-4.22%

Company Update

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Glenmark Pharmaceuticals Ltd.

07 Apr 2025, 07:25AM

1451.35

-3.23%

Company Update

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Appointment of Senior Management Personnel of the Company

pdf

Dr. Reddy's Laboratories Ltd.

05 Apr 2025, 10:42PM

1092.65

-1.56%

Dr Reddy's gets over Rs 2,395 crore show cause notice from I-T authority

Business Standard

Dr Reddy's Laboratories Ltd on Saturday said it has received a showcause notice from the income tax authority with a proposed demand of over Rs 2,395 crore from it related to the merger of Dr Reddy's Holding Ltd (DRHL) with itself. The company has received a show cause notice on April 4, 2025, from the office of the Assistant Commissioner of Income Tax, Hyderabad, Dr Reddy's Laboratories Ltd said in a regulatory filing. It requires the company to respond as to why notice should not be issued for assessment of income alleged to be escaped from tax consequent to the merger of DRHL into Dr Reddy's Laboratories Ltd (DRL) under the scheme of amalgamation approved by the National Company Law Tribunal (NCLT), Hyderabad on April 5, 2022, the filing added. "The notice quantifies the proposed demand of Rs 23,95,81,79,470," the company said. DRL asserted that said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws. "Further this was approved by

Number of FII/FPI investors decreased from 957 to 927 in Dec 2024 qtr

Dr. Reddy's faces 2,395 crore tax reassessment notice

Business Line | 05 Apr 2025, 09:46PM

Syncom Formulation (India) Ltd.

05 Apr 2025, 06:04PM

16.09

-6.29%

Company Update

Syncom Formulations India Ltd-$ - 524470 - Announcement Under Regulation 30

BSE India

Announcement under Regulation 30 for the demand raised under section 74 (5) of CGST ACT, 2017

pdf

Eris Lifesciences Ltd.

05 Apr 2025, 05:58PM

1256.75

-4.89%

Company Update

Eris Lifesciences Ltd - 540596 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018

pdf

Metropolis Healthcare Ltd.

05 Apr 2025, 02:37PM

1485.15

-4.22%

Company Update

Metropolis Healthcare Ltd - 542650 - Business Update For Q4FY25

BSE India

Business update for Q4FY25

pdf

Aurobindo Pharma Ltd.

05 Apr 2025, 02:31PM

1087.10

-1.65%

Company Update

Aurobindo Pharma Ltd - 524804 - Curateq Biologics Received Marketing Authorization For Dyrupeg(tm), A Pegylated Filgrastim …

BSE India

Intimation of receipt of Marketing authorisation by Curateq Biologics s.r.o, a wholly owned step down subsidiary of the Company.

pdf

Lincoln Pharmaceuticals Ltd.

05 Apr 2025

533.05

-5.67%

Company Update

Lincoln Pharmaceuticals Ltd - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participant) Regulations, 2018, we hereby submit the confirmation certificate as received from M/S. MUFG Intime India Private Limited, Register and Share Transfer Agent (RTA) for the Quarter ended March 31, 2025.

pdf